Global Laparoscopic Adjustable Gastric Band Market Size By Type (Lap-Band, Realize Band), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Laparoscopic Adjustable Gastric Band (LAGB) Market was valued at USD 327 million in 2023 and is projected to reach USD 522 million by 2031, growing at a CAGR of 6.0% during the forecast period from 2023 to 2031. The market growth is primarily driven by the rising prevalence of obesity and metabolic disorders, increasing preference for minimally invasive bariatric procedures, and growing awareness of weight management surgeries. The laparoscopic adjustable gastric band, a device used to restrict food intake and promote weight loss, continues to gain traction globally due to its reversibility, adjustability, and relatively lower complication rates compared to other bariatric procedures.

Drivers:

Rising Obesity Rates:

The global obesity epidemic has led to an increased demand for effective weight management interventions. LAGB is widely recognized for its efficacy in aiding long-term weight reduction, especially among individuals with severe obesity who have not succeeded with diet and exercise alone.

Preference for Minimally Invasive Procedures:

Laparoscopic surgeries offer shorter recovery times, lower postoperative complications, and minimal scarring. As a result, patients and healthcare providers are increasingly opting for minimally invasive approaches such as LAGB over traditional open surgeries.

Growing Awareness and Health Campaigns:

Public health campaigns and increasing media coverage about the risks of obesity and available surgical interventions have significantly boosted patient awareness, thereby encouraging consultations and surgical procedures.

Restraints:

Declining Popularity Compared to Other Bariatric Surgeries:

In recent years, the LAGB procedure has seen a slight decline in popularity due to the emergence of alternative bariatric procedures like sleeve gastrectomy and gastric bypass, which offer greater weight loss and fewer long-term complications.

Risk of Complications and Reoperations:

Although generally considered safe, LAGB procedures carry risks such as band slippage, erosion, and port-related complications, often necessitating reoperations. These risks may deter both patients and surgeons from choosing this option.

Opportunity:

Technological Advancements in Band Design:

Innovations such as remote-adjustable bands, biocompatible materials, and real-time monitoring systems present significant opportunities for market expansion by improving patient comfort, reducing complications, and enhancing long-term outcomes.

Untapped Emerging Markets:

Regions such as Asia-Pacific and Latin America, where obesity rates are rising but bariatric surgery penetration is still low, offer substantial growth potential for market players investing in education, affordability, and healthcare accessibility.

Market by System Type Insights:

Based on system type, the Adjustable Gastric Bands with Remote Control Features segment is anticipated to experience the fastest growth during the forecast period. These technologically advanced systems allow non-invasive adjustments and enhance patient convenience and compliance. However, the Standard Adjustable Gastric Bands segment held the largest share in 2023 due to their established clinical use, cost-effectiveness, and widespread availability.

Market by End-use Insights:

The Hospitals segment dominated the market in 2023, accounting for the largest revenue share, driven by the availability of skilled bariatric surgeons and comprehensive post-surgical care facilities. Meanwhile, the Ambulatory Surgical Centers (ASCs) segment is expected to witness higher growth due to increased adoption of outpatient bariatric procedures and their cost-efficiency.

Market by Regional Insights:

North America led the global LAGB market in 2023, owing to high obesity prevalence, a well-developed healthcare infrastructure, and favorable insurance policies. However, the Asia-Pacific region is projected to exhibit the fastest growth during the forecast period due to the rising middle-class population, growing health awareness, and improving access to advanced surgical procedures.

Competitive Scenario:

Key players in the Global Laparoscopic Adjustable Gastric Band Market include Apollo Endosurgery Inc., Johnson & Johnson (Ethicon Inc.), ReShape Lifesciences Inc., Cousin Biotech, Medtronic plc, B. Braun Melsungen AG, and MIDBAND Medical GmbH. These companies are focusing on new product development, clinical trials, and strategic collaborations to enhance their market presence. For instance:

In 2024, ReShape Lifesciences announced the FDA clearance of its next-generation adjustable gastric band designed to reduce port-related complications.

Apollo Endosurgery expanded its distribution network across Southeast Asia in 2023, aiming to capture emerging market opportunities.

Scope of Work – Global Laparoscopic Adjustable Gastric Band Market

Report Metric Details

Market Size (2023) USD 327 million

Projected Market Size (2031) USD 522 million

CAGR (2023–2031) 6.0%

Market Segments By System Type (Standard, Remote Adjustable), By End-Use (Hospitals, ASCs), By Region

Growth Drivers Rising obesity rates, demand for minimally invasive procedures, awareness of weight-loss solutions

Opportunities Technological innovation in band systems, expansion in emerging markets

Key Market Developments:

2023: Johnson & Johnson unveiled a refined laparoscopic toolset to improve precision in adjustable gastric band placement procedures.

2024: Apollo Endosurgery entered a strategic partnership with bariatric clinics in Brazil to expand access to affordable LAGB surgeries.

2025: ReShape Lifesciences introduced an AI-based monitoring platform for post-operative tracking of band adjustment needs.

FAQs:

What is the current market size of the Global Laparoscopic Adjustable Gastric Band Market?

The market was valued at USD 327 million in 2023.

What is the major growth driver of the Global Laparoscopic A